Brief: Tela Bio Announces Sale Of Distribution Rights For Wound Care Product To Mimedx
March 20 (Reuters) - TELA Bio Inc TELA.O :
* TELA BIO ANNOUNCES SALE OF DISTRIBUTION RIGHTS FOR WOUND
CARE
PRODUCT TO MIMEDX
* TELA BIO INC - AS CONSIDERATION FOR SALE, MIMEDX WILL MAKE
AN
INITIAL $5.0 MILLION PAYMENT
* TELA BIO- MIMEDX WILL MAKE FUTURE PAYMENTS BETWEEN
MINIMUM OF
$3.0 MILLION AND $7.0 MILLION BASED ON NET SALES OF NIVIS OVER
NEXT TWO YEARS
Source text for Eikon: ID:nGNXbYWJ87
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million